Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome
World Journal of Cardiology · 26.06.2024 · 16 (6) · 329-338
DOI: 10.4330/wjc.v16.i6.329 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Cardiology, online erschienen am 26.06.2024. Verfasst von Yasuhiko Saeki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kanazawa Medical University, Uchinada 9200293, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular diseases; however, its role in acute coronary syndrome (ACS) remains unclear. AIM To investigate the hypothesis that the Lp(a) levels are altered by various conditions during the acute phase of ACS, resulting in subsequent cardiovascular events. METHODS From September 2009 to May 2016, 377 patients with ACS who underwent emergent coronary angiography, and 249 who completed ≥ 1000 d of follow-up were enrolled. Lp(a) levels were measured using an isoform-independent assay at each time point from before percutaneous coronary intervention (PCI) to 48 h after PCI. The primary endpoint was the occurrence of major adverse cardiac events (MACE; cardiac death, other vascular death, ACS, and non-cardiac vascular events). RESULTS The mean circulating Lp(a) level decreased significantly from pre-PCI (0 h) to 12 h after (19.0 mg/dL to 17.8 mg/dL, P < 0.001), and then increased significantly up to 48 h after (19.3 mg/dL, P < 0.001). The changes from 0 to 12 h [Lp(a)Δ0-12] significantly correlated with the basal levels of creatinine [Spearman’s rank correlation coefficient (SRCC): -0.181, P < 0.01] and Lp(a) (SRCC: -0.306, P < 0.05). Among the tertiles classified according to Lp(a)Δ0-12, MACE was significantly more frequent in the lowest Lp(a)Δ0-12 group than in the remaining two tertile groups (66.2% vs 53.6%, P = 0.034). A multivariate analysis revealed that Lp(a)Δ0-12 [hazard ratio (HR): 0.96, 95% confidence interval (95%CI): 0.92-0.99] and basal creatinine (HR: 1.13, 95%CI: 1.05-1.22) were independent determinants of subsequent MACE. CONCLUSION Circulating Lp(a) levels in patients with ACS decreased significantly after emergent PCI, and a greater decrease was independently associated with a worse prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Kanazawa Medical University, Uchinada 9200293, Japan.
- Trans-catheter Cardiovascular Therapeutics, Kanazawa Medical University, Uchinada 9200293, Japan.
- Department of Cardiology, Kanazawa Medical University, Uchinada 9200293, Japan. kajinami@kanazawa-med.ac.jp.
Zitieren
APA
Saeki, Y., Sawaguchi, J., Akita, S., Takamura, T. A., Fujibayashi, K., Wakasa, M., Akao, H., Kitayama, M., Kawai, Y., & Kajinami, K. (2024). Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World Journal of Cardiology, 16(6), 329-338. https://doi.org/10.4330/wjc.v16.i6.329
Vancouver
Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, et al. Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World Journal of Cardiology. 2024;16(6):329-338. doi:10.4330/wjc.v16.i6.329
BibTeX
@article{Saeki2024,
author = {Saeki, Yasuhiko and Sawaguchi, Jun and Akita, Satori and Takamura, Taka-Aki and Fujibayashi, Kosuke and Wakasa, Minoru and Akao, Hironobu and Kitayama, Michihiko and Kawai, Yasuyuki and Kajinami, Kouji},
title = {Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome},
journal = {World Journal of Cardiology},
year = {2024},
volume = {16},
number = {6},
pages = {329--338},
doi = {10.4330/wjc.v16.i6.329}
}
EUVIMED